Amonoo Hermioni L, Guo Michelle, Keane Emma P, Boardman Annabella C, Song M Tim, Wolfe Emma D, Cutler Corey, Jim Heather S, Lee Stephanie J, Huffman Jeff C, El-Jawahri Areej
Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Transplant Cell Ther. 2024 Dec;30(12):1217.e1-1217.e15. doi: 10.1016/j.jtct.2024.09.022. Epub 2024 Sep 26.
Although peer support interventions are associated with improved patient-reported outcomes in diverse cancer populations, structured peer support programs tailored to the needs of patients undergoing hematopoietic stem cell transplantation (HSCT) are lacking. This single-arm, proof-of-concept trial aimed to refine the Supporting Transplant Experiences with Peer Program (STEPP), a structured, five-session, manualized, phone-delivered peer support intervention for patients undergoing HSCT, informed by qualitative feedback from patients. Adult patients with hematologic malignancies scheduled to undergo allogeneic or autologous HSCT were eligible to participate in the study approximately two weeks prior to their HSCT hospitalization. Participants received the STEPP intervention, which focused on providing informational, emotional, and practical support. To refine the intervention, we conducted semi-structured qualitative exit interviews to gather feedback on the content of STEPP and to identify facilitators and barriers to engagement. Transcribed interviews were analyzed using rapid analytic methods by two coders. Of the 37 eligible patients, 25 enrolled in the study, 20 completed all intervention sessions and 20 completed exit interviews. Participants highlighted that discussions with peer mentors/STEPP interventionists about the transplant journey and processing information provided by the clinical team were the most valuable aspects of STEPP. Positive experiences during the first intervention session facilitated patient engagement with the program. Potential barriers to engagement included logistical challenges in connecting with interventionists while experiencing physical symptoms during inpatient hospitalization and being paired with an interventionist who had a different cancer diagnosis and/or type of transplant. Patients undergoing HSCT reported positive experiences with the structured five-session, phone-delivered peer support intervention administered before and during the HSCT hospitalization. Patients' descriptions of barriers and facilitators to engagement with the STEPP intervention underscore the importance of patient input and programmatic structure in peer support interventions for this population. Insights from this proof-of-concept trial will be incorporated into future trials of STEPP to improve outcomes in HSCT recipients.
尽管同伴支持干预与不同癌症患者群体中患者报告的结局改善相关,但针对接受造血干细胞移植(HSCT)患者需求的结构化同伴支持项目却很缺乏。这项单臂概念验证试验旨在完善同伴支持移植体验项目(STEPP),这是一个为接受HSCT的患者提供的结构化、五节、手册化、通过电话提供的同伴支持干预项目,该项目参考了患者的定性反馈。计划接受异基因或自体HSCT的血液系统恶性肿瘤成年患者在其HSCT住院前约两周有资格参与本研究。参与者接受了STEPP干预,该干预侧重于提供信息、情感和实际支持。为了完善干预措施,我们进行了半结构化的定性退出访谈,以收集对STEPP内容的反馈,并确定参与的促进因素和障碍。两名编码员使用快速分析方法对转录的访谈进行了分析。在37名符合条件的患者中,25名登记参加了研究,20名完成了所有干预环节,20名完成了退出访谈。参与者强调,与同伴导师/STEPP干预人员讨论移植过程以及处理临床团队提供的信息是STEPP最有价值的方面。第一次干预环节中的积极体验促进了患者对该项目的参与。参与的潜在障碍包括在住院期间出现身体症状时与干预人员联系存在后勤挑战,以及与患有不同癌症诊断和/或移植类型的干预人员配对。接受HSCT的患者报告了在HSCT住院前和住院期间实施的结构化五节、通过电话提供的同伴支持干预有积极体验。患者对参与STEPP干预的障碍和促进因素的描述强调了患者意见和项目结构在针对该人群的同伴支持干预中的重要性。这项概念验证试验的见解将纳入未来的STEPP试验,以改善HSCT接受者的结局。